Tempest Therapeutics, Inc. Equity Method Investment, Summarized Financial Information, Gross Profit (Loss) (Deprecated 2020-01-31)
Tempest Therapeutics, Inc. (TPST) reported Equity Method Investment, Summarized Financial Information, Gross Profit (Loss) (Deprecated 2020-01-31) of $500.00 thousand for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-11.
Discontinued › Income Statement › Other Income
us-gaap:EquityMethodInvestmentSummarizedFinancialInformationGrossProfitLoss · last filed 2015-05-11
- Tempest Therapeutics, Inc. equity method investment, summarized financial information, gross profit (loss) (deprecated 2020-01-31) for the quarter ending 2015-03-31 was $500.00K, a 400.00% increase year-over-year.
- Tempest Therapeutics, Inc. equity method investment, summarized financial information, gross profit (loss) (deprecated 2020-01-31) for the quarter ending 2014-09-30 was $500.00K.
- Tempest Therapeutics, Inc. equity method investment, summarized financial information, gross profit (loss) (deprecated 2020-01-31) for the quarter ending 2014-06-30 was $300.00K.
- Tempest Therapeutics, Inc. equity method investment, summarized financial information, gross profit (loss) (deprecated 2020-01-31) for the quarter ending 2014-03-31 was $100.00K.
| Period end | Equity Method Investment, Summarized Financial Information, Gross Profit (Loss) (Deprecated 2020-01-31) 3 month | Equity Method Investment, Summarized Financial Information, Gross Profit (Loss) (Deprecated 2020-01-31) 6 month | Equity Method Investment, Summarized Financial Information, Gross Profit (Loss) (Deprecated 2020-01-31) 9 month |
|---|---|---|---|
| 2015-03-31 | $500.00K 10-Q · filed 2015-05-11 | ||
| 2014-09-30 | $500.00K 10-Q · filed 2014-11-10 | $800.00K derived: sum of 2 quarters · filed 2014-11-10 | $900.00K 10-Q · filed 2014-11-10 |
| 2014-06-30 | $300.00K 10-Q · filed 2014-08-07 | $400.00K 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $100.00K 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |